Uncategorized
Denali Therapeutics’ Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
Denali’s DNL343 missed efficacy goals in the HEALEY ALS trial but was well-tolerated. Analysts await detailed biomarker data and subgroup analyses in 2025. Latest Ratings for DNLI Date Firm Action From To Jan 2022 Morgan Stanley Maintains Overweight Sep 2021 Oppenheimer Initiates Coverage On Outperform Aug 2021 Morgan Stanley Maintains Overweight View More Analyst Ratings…
CFTC Chairman Rostin Behnam To Step Down In February
Chairman of the U.S. Commodity Futures Trading Commission Rostin Behnam resigns, leaving the agency stronger and more focused on regulating cryptocurrency. read more
Coca-Cola’s Strong Exposure To Emerging Markets Is Key To Sustainable Growth, Says Bullish Analyst
Coca-Cola Co has attractive and sustainable growth drivers, including exposure to emerging markets, according to Piper Sandler analyst Michael Lavery. With a price target of $74, Coca-Cola’s strong marketing and franchised bottling system contribute to its long-term growth. Latest Ratings for KO Date Firm Action From To Feb 2022 Deutsche Bank Maintains Hold Feb 2022…
Logitech’s Streamlabs Teams With NVIDIA To Simplify Streaming With AI
LOGI shares up premarket as Streamlabs partners with NVIDIA and Inworld AI to launch AI-powered streaming assistant, enhancing live streaming experience. read more
2 People Found Dead In Landing Gear Well Of JetBlue Airways Plane Following Flight To Florida: ‘This Keeps Happening’
Two bodies were discovered inside the wheel well of a JetBlue Airways Corp (NASDAQ:JBLU) plane after landing in Florida on Monday night. Here’s what you need to know. read more
